ACSL4 and neoplasm: In tumor cell, tumor suppressor gene RB1 mutation upregulates the levels of ACSL4 and enriches ACSL4-dependent arachidonic acid–containing (AA–containing) phospholipids which increase tumor cell vulnerability to ferroptosis [8].